Sign in

NCT06586983Active, not recruiting

Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

The goal of this observational study is to study models of care for decentralized hepatitis B treatment in Ethiopia. Three different models of decentralized HBV care (standard model, simplified model, test-and-treat model) will be implemented at primary hospitals or health clinics in Ethiopia. Treatment will be given for free to patients who meet the treatment criteria. We will compare clinical outcome, laboratory outcomes and programmatic outcome measures between the 3 models.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
4500 (estimated)
First submitted
4 Sept 2024
Start date
4 Sept 2024
Primary completion date
5 Sept 2028
Lead sponsor
Oslo University Hospital
Diseases
Hepatitis B
NCT number
NCT06586983

What you commit to

  • Study type: Observational
  • Planned participants: 4500
  • From 4 Sept 2024 to the primary completion date, 5 Sept 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other disease with short life expectancy (disseminated cancer etc.)

Age

  • Below 18 years of age.

Other

  • Negative HBsAg rapid test at screening visit.

Who the study is looking for

  • Adult (at least 18 years of age) who is HBsAg positive.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Addis Ababa University
Coordinator of this site? Confirm its status
Addis AbabaEthiopiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.